Joe Wyse

Dr. Wyse is President, CEO and partner at BAM and brings over 28 years of business experience in the life science to the BAM team. Dr. Wyse’s business background includes intellectual property management, patent landscape analysis, technology valuation and strategic options assessments. Dr. Wyse’s scientific background in chemistry gives him a unique perspective to craft targeted business strategies.

Formerly, Dr. Wyse founded Wyse Innovations in 2010, a consultancy focused on assisting clients in maximizing the value of their intellectual assets. Dr. Wyse served as CEO of Coldstream Laboratories, Inc, a contract pharmaceutical development and licensing company, in 2007 as a spin- off of the University of Kentucky College of Pharmacy. Under his leadership Coldstream Laboratories achieved FDA approval for commercial manufacture of a generic injectable drug product.

Dr. Wyse served five years at PriceWaterhouseCoopers where he was Director and founding member of PwC’s Intellectual Asset Management practice. During that time led the effort to develop and apply proprietary data-mining tools that provide strategic insights into a client’s and competitor’s intellectual property portfolios.

Dr. Wyse received his bachelor degree in Chemistry from Asbury College. He completed his Doctor of Philosophy in Chemistry from the University of Kentucky.